Study shows that monthly doses of two common anti-malarial drugs for the first few years of life can provide 95 percent protection against the disease.
Scientists at the UCSF Quantitative Biosciences institute developed a new approach for understanding cancer and applied it to breast cancer and cancers of the neck and head